EU Court Adviser Challenges 80% Cost-Sharing Rule for Microplastic Cleanup
Published on 09/09/2026 at 16:04 | Editorial boerse-global.de
The legal foundation of Europe's ambitious wastewater treatment expansion is now under serious question, following a top adviser's recommendation that the bloc's courts strike down a key financing provision.
Advocate General Kokott issued her opinion on September 3, 2026, urging the European Court of Justice to invalidate central elements of the EU Urban Wastewater Treatment Directive. Trade publications covering the development on September 8 and 9 detailed what the adviser described as clear errors in how the regulation was researched and assessed — specifically regarding the financial obligations it places on private companies.
Where the legal battle centers
The dispute revolves around Article 9(1) of the directive, which assigns the pharmaceutical and cosmetics industries responsibility for 80 percent of the costs tied to upgrading treatment plants with what is known as a fourth purification stage. That additional treatment layer targets micropollutants — residues from medicines and ingredients found in personal care products — that slip through conventional filtration.
Kokott's opinion contends that the EU failed to adequately justify imposing such a steep cost share on manufacturers. Her recommendation aligns with the arguments long advanced by industry representatives.
The European Federation of Pharmaceutical Industries and Associations, together with individual companies such as Fresenius Kabi, had previously challenged the rules in court. Those cases were dismissed by the EU's General Court on procedural grounds, though the underlying objections never received a full merits review.
Industry warnings about supply and pricing
German industry associations have been vocal in their opposition to the original framework. The German Pharmaceutical Industry Association argued that loading the financial burden disproportionately onto producers would distort competition within the single market. Its members fear higher medicine prices and possible supply bottlenecks that could undermine patient care across the bloc.
The German Chemical Industry Association has likewise voiced reservations about the directive in its present form. Rather than singling out two sectors to foot the bill, the group advocates financing models that spread infrastructure costs more evenly across all contributors to the wastewater stream.
Water sector defends the polluter-pays approach
Not everyone shares that view. Water management organizations are pushing back, insisting that accountability for contamination must sit with those who introduce problematic substances into the water cycle.
Ulrich Paetzel, president of the German Association for Water, Wastewater and Waste, reaffirmed that the fourth purification stage remains indispensable for environmental protection. From his sector's standpoint, requiring polluters to shoulder a fair portion of cleanup expenses is not just reasonable — it is essential to keeping Europe's waterways healthy.
The technical necessity of upgrading treatment infrastructure is something few dispute, even amid the legal wrangling over who should pay for it. The fourth stage is widely regarded as the most effective available method for reducing ecosystem exposure to persistent chemical compounds that resist natural breakdown.
What happens next
While the advocate general's opinion carries no binding weight, the European Court of Justice typically follows such recommendations in its rulings. A final judgment on whether the 80 percent cost-sharing provision stands is anticipated by the end of 2026.
Should the court side with Kokott, EU lawmakers would be forced back to the drawing board — not only on how to fund the fourth purification stage, but on the entire legal rationale underpinning producer responsibility under the directive. That would mean reopening a politically sensitive file that balances industrial competitiveness against environmental commitments, with billions of euros in infrastructure investment hanging in the balance.
